Literature DB >> 15580468

[The role of the immune system in hereditary demyelinating neuropathies].

M Mäurer1, K V Toyka, R Martini.   

Abstract

Hereditary neuropathies, e.g., Charcot-Marie-Tooth (CMT) disease, are inherited diseases of the peripheral nervous system causing chronic progressive motor and sensory dysfunction. Most neuropathies are due to mutations in myelin genes such as PMP22, P0, and the gap junction protein Cx32. Myelin mutant mice are regarded as suitable animal models for several forms of hereditary neuropathies and are important neurobiological tools for the evaluation of pathogenetic and therapeutic concepts in hereditary neuropathies. Using these animal models we could recently show that the immune system is involved in the pathogenesis of hereditary neuropathies. Due to the phenotypic similarities we also consider the immune system important for human inherited neuropathies, in particular since several case reports demonstrate a beneficial effect of immune therapies in patients with hereditary neuropathies. In this review we compare findings from animal models and human disease to elucidate the role of the immune system in hereditary neuropathies.

Entities:  

Mesh:

Year:  2005        PMID: 15580468     DOI: 10.1007/s00115-004-1841-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Corticosteroid-responsive dominantly inherited neuropathy in childhood.

Authors:  S J Bird; J T Sladky
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

2.  Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies.

Authors:  R Kiefer; B C Kieseier; W Brück; H P Hartung; K V Toyka
Journal:  Brain       Date:  1998-03       Impact factor: 13.501

3.  Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants.

Authors:  M Mäurer; C D Schmid; F Bootz; J Zielasek; K V Toyka; S Oehen; R Martini
Journal:  Mol Cell Neurosci       Date:  2001-06       Impact factor: 4.314

4.  Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies.

Authors:  P W Lampert
Journal:  Lab Invest       Date:  1969-02       Impact factor: 5.662

Review 5.  Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.

Authors:  P Young; U Suter
Journal:  Brain Res Brain Res Rev       Date:  2001-10

6.  Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I).

Authors:  A A Gabreëls-Festen; E M Joosten; F J Gabreëls; F G Jennekens; T W Janssen-van Kempen
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

7.  Acute inflammatory neuropathy in Charcot-Marie-Tooth disease.

Authors:  A Malandrini; M Villanova; M T Dotti; A Federico
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

8.  Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation.

Authors:  M Donaghy; S M Sisodiya; R Kennett; B McDonald; N Haites; C Bell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

9.  Influence of injury and cytokines on synthesis of monocyte chemoattractant protein-1 mRNA in peripheral nervous tissue.

Authors:  M C Subang; P M Richardson
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

10.  Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination.

Authors:  R H Ballin; P K Thomas
Journal:  J Neurol Sci       Date:  1969 Jan-Feb       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.